SITE MAP 
  HOME  
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
  JOBS  
  FREE SUBSCRIPTION  
  Friday, May 23, 2008 SEARCH     
 
 
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement





















 
Medical Technology  R & D  Story
A new blood test to detect heart failure warning signs

Singapore, Sep 27, 2007: Monash University’s Centre of Clinical Research Excellence in Therapeutics is working on a new blood test to detect early warning signs of heart failure.
 
Lead researcher for the medical trial, Monash University's Professor Henry Krum said the Centre of Clinical Research Excellence is working with health insurer HBA to trial the blood tests outside of a hospital setting.
 
“It is the first time in the world such a large trial of the blood tests have been conducted in the community,” Professor Krum said. “So far these blood tests have been effective in diagnosing heart failure in hospitals during emergency situations,” Professor Krum said.
 
The researcher in the press release has indicated that this trial may help to show how a simple blood test can be used well before any heart failure symptoms or significant damage to the heart occurs.
 
Heart failure is an ongoing condition that occurs when the heart muscle works less efficiently than normal and cannot pump as well as it usually does. Because of heart failure the heart may become enlarged or thickened and weaken over time.
 
The researcher explains that when the heart is under increased pressure or stress a hormone, known as Brain Natriuretic Peptide (BNP) is released into the blood stream. This is the first known indicator of heart failure. Currently the only way to detect heart failure is after damage to the heart has been done and by using tests, such as, an Echocardiogram.
 
This study aims to show that by doing a simple blood test for this hormone will help recognize someone with a higher risk of heart failure, before any other signs are known. At every stage of the trial, participants will be consulted by trained medical researchers who can help advise them on the outcomes of their test and direct them to the appropriate medical services for further assistance if required. It is anticipated that the results of this important medical study will be available before the end of the year.
 
An estimated 300,000 Australians live with heart failure and a further 30,000 Australians are diagnosed annually. Studies have shown that up to 10 per cent of people with heart failure die within 12 months of diagnosis.

© BioSpectrum Bureau
  Email this articleComment on this article   Print this article
 
Advertisement





 
   
 
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[CIOL Shop]  [DQ Channels]  [The DQweek]  [CyberMedia Dice]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black